It is possible, that the reduction of E-cadherin expression promotes tumour development by enhancing β-catenin nuclear activity, yet is caused by mechanisms different from CTNNB1 homozygous mutations in both, CRC cell line LS180 and CRC tissue. The gene discussed is CTNNB1; the disease is colorectal carcinoma.